Part of the challenge is to do a better job of helping patients make their own, well-informed choices.
Measure of Mpl gene expression reveals a heterogonous population of leukemia stem cells: one group leukemic and the other group non-leukemic.
The Nov. 10 workshop will provide information and resources for lung cancer patients.
Published in Focus on Patient Care
The UAB Comprehensive Cancer Center ranked as one of 100 Hospitals and Health Systems with great oncology programs in America.
Published in Focus on Patient Care
A drug derived from female hormones that may help soldiers survive major blood loss on a battlefield will undergo first human testing at UAB.
Wrong shipment of mice led to estrogen breakthrough in trauma survival.
UAB researcher reports that brentuximab vedotin may be effective therapy for older patients with Hodgkin Lymphoma who cannot tolerate standard therapy.
Published in Focus on Patient Care
New UAB research demonstrates social factors that determine survival of younger patients with AML and present opportunities to improve outcomes.
Published in Focus on Patient Care
UAB offers two national clinical trials with customized treatment for lung cancer patients.
Published in Focus on Patient Care
Elevated PARP1 polymerase in HER2+ breast cancer may confer susceptibility to PARP inhibitor drugs.
Internationally renowned husband and wife cancer researchers join UAB and showcase its  recruitment muscle

Weakened immune systems due to diseases like cancer cause increased risk of severe complications from the flu virus — experts advise vaccine shot, not mist.

Published in News You Can Use

PNP Therapeutics, UAB and Southern Research Institute work abolishes otherwise unmanageable human cancers in preclinical rodent studies.

Biomarkers could tailor preventative or therapeutic aspirin regimens by predicting colorectal cancer patients’ response.
UAB cancer expert provides the deeper understanding on summer skin protection from UV rays, offers helpful tips.
Published in News You Can Use

“Complementary and Alternative Therapies: What You (And Your Doctor) Don’t Know Can Hurt You” to be held Jan. 24

Published in Service to Community
New clinic provides high-quality care with infusion therapy to Bessemer and Tuscaloosa-area communities.
Published in Focus on Patient Care
NEJM study shows aspirin has the potential to block tumor growth in certain colorectal cancer patients.
Published in Focus on Patient Care

Friedman will conduct research on medulloblastoma, the most common malignant brain tumor found in children.

Harry P. Erba, M.D., Ph.D., the inaugural holder of the Albert F. LoBuglio Endowed Chair for Translational Cancer Research
Published in Faculty Excellence
Page 1 of 3
Back to Top